Access Menu

Log in via Social

Log in with LinkedIn
Onko Solutions

Onko Solutions

We develop advanced and innovative solutions to detect and prevent cancer in underserved populations.

This company and others may be fundraising.

Login or signup to access deals.

Company Overview

Onko Solutions, LLC is a company committed to the development and commercialization of innovative technology solutions that contribute to the detection, prevention and treatment of cancer in underserved populations.

We are dedicated to transforming lives with reliable solutions in the detection and treatment of cancer that offer immediate results and are affordable for everyone.

We are currently working in early cervical cancer detection. Mortality related to cervical cancer is rare among women who get screened regularly. However, only 40 to 50% of women in developed countries get screened every year, while in underdeveloped countries that number drops to an alarming 5%.

There is an urgent need for palpable, cost-effective, reproducible and non-invasive solutions that significantly reduce the fatalities attributed to cervical cancer. Such solutions are especially urgent in developing countries that lack the resources and equipment to perform cytodiagnosis.

Onko Solutions has developed a portable medical device for effective, reliable, fast and non-invasive screening for cervical cancer that unlike Pap smears, HPV tests, or biopsies, does not require laboratory analysis or a tissue sample, making it ideal and available to underprivileged regions.

Our device is designed to provide non-invasive screening with instantaneous results, eliminating costly, painful and unnecessary lab work.


18,000 Users
$900,000 Sales
2 Issued Patents


  • Verbal Commitment from 2 institutional investors for another $650,000 USD investment pending a trial of 150 women in Guadalajara, MX.

    July, 2015
  • Regulatory approval (TruScreen by Onko Solutions)

    July, 2015
  • Sales begin in Mexico (TruScreen by Onko Solutions)

    August, 2015
  • Complete product development of proprietary solution

    November, 2015
  • Complete clinical trials of proprietary solution

    December, 2015
  • Proprietary product receives approval to be marketed in Mexico

    February, 2016
  • Sales begin in Mexico

    April, 2016
  • Sales begin in Latin America

    June, 2016
  • Technology feasibility testing for FDA approval

    May, 2016
  • Present pre-submission package for FDA approval

    August, 2016
  • Initiate clinical trials FDA/CE Mark

    October, 2016


Martin F.
Martin F.
Gynecologist, Private Sector
"“This device will revolutionize the field of preventive health for women. It combines and eliminates everything that is stopping the Pap test from being a routine test for all the women in the world.”"
Guillermo A.
Guillermo A.
Gynecologist, Private Sector
""This method removes the taboo and psychological elements that keep many women away from a Pap test; elements that may also cause many to erroneously dismiss it as a non-essential test.""
Sarah C.
Sarah C.
Gynecologist, Private Sector
"“The immediate results would make me feel calm and safe. This device makes the Pap test seem obsolete.”"
Sandra G.
Sandra G.
"“I believe this technology will take away the fear caused by a Pap test and eradicate the ache and discomfort that this test brings to so many of us.”"